Press release
Cancer Gene Therapy Market: Growth & Revenue Opportunities by Top Key Players - Adaptimmune, GlaxoSmithKline, Bluebird bio, Inc., Merck, Celgene, Shanghai Sunway Biotech, BioCancell
Cancer Gene Therapy Market is estimated to reach $2,082 million by 2023, registering a CAGR of 32.4% from 2017 to 2023. North America is the highest contributor in the cancer gene therapy market in 2016; however, Asia-Pacific is expected to witness the highest growth rate.Cancer gene therapy is an approach for the cancer treatment, where genetically engineered vectors such as viruses are used to transfer or replace a mutated gene (that is causing cancer) with a heathy gene. This technique can be used for both the prevention and treatment of disease. The most commonly used techniques for the treatment using cancer gene therapy includes oncolytic virotherapy, gene transfer, and gene-induced immunotherapy.
Buy now and get FREE One Month Knowledge Tree Subscription (valid till 30 Nov'18): https://www.alliedmarketresearch.com/checkout/506429?utm_source=sy-Openpr
The rise in prevalence of cancer, ethical acceptance of gene therapy for cancer treatment, and the advancement in this field drive the market growth. In addition, benefits of cancer gene therapy over conventional cancer therapies, increase in government support, and rise in biotechnological funding that encourage the R&D activities for cancer gene therapy fuel the growth of the cancer gene therapy market. However, high cost associated with the treatment and unwanted immune responses are expected to restrain the market growth.
The key companies profiled in the report include
• Adaptimmune
• GlaxoSmithKline
• Bluebird bio Inc.
• Merck
• Celgene
• Shanghai Sunway Biotech
• BioCancell
• Shenzhen SiBiono GeneTech
• SynerGene Therapeutics
• OncoGenex Pharmaceuticals.
Among the therapy segment, oncolytic virotherapy segment is the largest contributor toward the market growth and gene transfer therapy segment is anticipated to be a lucrative market due to the positive results for these therapies during the preclinical and clinical trials for the treatment of cancer.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2605?utm_source=sy-Openpr
In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of cancer, presence of high disposable income, and high funding for R&D activities associated with cancer gene therapy. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in incidence rate of cancer, increase in government initiative to improve healthcare infrastructure, and rise in healthcare expenditure.
Key Findings of the Cancer Gene Therapy Market:
• Gene tranfer segment is projected to grow at the highest rate during the analysis period.
• Oncolytic virotherapy segment generated the highest revenue, and is expected to continue its dominance in the future.
• North America dominated the global cancer gene therapy market, and is projected to continue its dominance in future.
• China is expected to grow highest in the Asia-Pacific region.
• Asia-Pacific is expected to be the fastest growing segment during the forecast period.
Access Full Summery @ https://www.alliedmarketresearch.com/press-release/cancer-gene-therapy-market.html?utm_source=sy-Openpr
About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Gene Therapy Market: Growth & Revenue Opportunities by Top Key Players - Adaptimmune, GlaxoSmithKline, Bluebird bio, Inc., Merck, Celgene, Shanghai Sunway Biotech, BioCancell here
News-ID: 1407955 • Views: …
More Releases from Allied Market Research
Dermocosmetics Market Research Report : Unveiling CAGR and USD Projections for K …
The global dermocosmetics market size was valued at $51.10 billion in 2021, and is projected to reach $130.46 billion by 2030, growing at a CAGR of 11.1% from 2022 to 2030. Dermocosmetics is a combination of two medical branches i.e., cosmetics and dermatology. Dermocosmetics aids all beauty concerns such as oily skin, dry skin, skin conditions like pimples, acne, marks, blemishes, and others. Evolving role of cosmetics in skin care…
Hemp Clothing Market Projected Expansion to Receive Overwhelming Hike In Revenue …
According to the report published by Allied Market Research, the global hemp clothing market generated $2.29 billion in 2021, and is projected to reach $23.02 billion by 2031, growing at a CAGR of 27.1% from 2022 to 2031.The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, and competitive landscape. The report is a…
Sustainable Home Décor Market Growing at 5.5% CAGR to Hit USD 556.3 billion by …
The global Sustainable Home Decor Market Size was valued at $331.0 billion in 2021, and is projected to reach $556.3 billion by 2031, growing at a CAGR of 5.5% from 2022 to 2031. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the market size and its proper segmentation help the market players define the…
Tomato Puree Market Rapidly Growing Dynamics with Industry Analysis 2032
The global tomato puree industry was valued at $5,189.9 million in 2022, and is projected to reach $7,699.5 million by 2032, registering with a CAGR of 4.1% from 2023 to 2032.
Tomato puree plays a major role in the daily culinary routines of individuals, making significant contributions to the global food and beverage industry. The growing awareness of diverse and authentic flavors, along with a rising interest in international cuisines, has…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
